Hepatitis C Management in Special Populations
Summary
- All patients with decompensated cirrhosis should be referred for liver transplantation but may be treated with interferon-free HCV therapy
- Use of DAA regimens is also recommended for the treatment of recurrent HCV in patients who have undergone liver transplantation Treatment of Hepatitis C Virus in Decompensated Cirrhosis or the Posttransplantation Setting
- The AASLD/IDSA (Management Guidelines)[AASLD-IDSA HCV] and EASL (Management Guidelines)[EASL HCV] guidance panels provide recommendations for the use of DAA regimens in the treatment of HCV infection in patients with decompensated cirrhosis: Table 12
Action required
- Login now to access all of your entitled content
or - View additional options to gain access to this content